ftInvstr
SUDEEPPHRM · Healthcare ₹1335.0 +3.33% Mkt Cap ₹15102 Cr

SUDEEPPHRM

Healthcare Drug Manufacturers - Specialty & Generic
₹1335.0
+3.33% today · 30d +36.92%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SUDEEPPHRM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹158 Cr
NET PROFIT
₹41 Cr
OPM
36.87%
EPS
₹3.59
PE 81.58
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.3% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SUDEEPPHRM81.5836.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
70
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
Valuation STRETCHED 20
Growth STRONG 78
Profitability HIGH 95
Technicals NEUTRAL 68
Risk LOW 90
Key Stats
TTM PE
81.58
P/B
16.92
52W HIGH
₹1357.4
OFF HIGH
-1.65%
DIV YIELD
0.11%
MKT CAP
₹15102 Cr
◉ Active Signals
MACDBullish12.5205
RSI(14)Bearish83.63
Near 52W HighBullish-1.65
Street Consensus
2 analysts
₹777.5
mean target
Low ₹700.0Now ₹1335.0High ₹855.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SUDEEPPHRM and at what entry.

Sign up freeSign in